|
|
||||||||
Journal of Applied Physiology, Vol 76, Issue 1 5-13, Copyright © 1994 by American Physiological Society
ARTICLES |
B. N. Cronstein
Department of Medicine, New York University Medical Center, New York 10016.
Adenosine receptors are present on most cells and organs, yet, although the physiological effects of adenosine were first described over 60 years ago, the potential therapeutic uses of adenosine have only been recognized and realized recently. A decade ago the potent anti-inflammatory effects of adenosine were first described; adenosine, acting at specific A2 receptors, inhibits some, but not all, neutrophil functions. Adenosine inhibits phagocytosis, generation of toxic oxygen metabolites, and adhesion (to some surfaces and to endothelial cells) but does not inhibit degranulation or chemotaxis. Occupancy of adenosine A2 receptors modulates leukocyte function by a novel mechanism. Although adenosine A2 receptors are classically linked to heterotrimeric GS signaling proteins and stimulation of adenylate cyclase, adenosine 3',5'-cyclic monophosphate does not act as the second messenger for inhibition of leukocyte function. By a mechanism that still remains obscure, occupancy of adenosine A2 receptors on neutrophils "uncouples" chemoattractant receptors from their stimulus-transduction proteins. The concentrations of adenosine that inhibit inflammatory cell function are similar to those observed in vivo and suggest a role for adenosine in the modulation of inflammation in vivo. Indeed, recent studies indicate that nonmetabolized adenosine receptor agonists are potent anti-inflammatory agents, and other studies indicate that methotrexate, a commonly used anti-inflammatory agent, diminishes inflammation by increasing adenosine release at inflamed sites. The observations reviewed here suggest that adenosine and agents that act through adenosine are excellent candidates for development as anti-inflammatory agents.
This article has been cited by other articles:
![]() |
M. Takedachi, D. Qu, Y. Ebisuno, H. Oohara, M. L. Joachims, S. T. McGee, E. Maeda, R. P. McEver, T. Tanaka, M. Miyasaka, et al. CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes J. Immunol., May 1, 2008; 180(9): 6288 - 6296. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Garcia, L. D. Truong, P. Li, P. Zhang, J. Du, J.-F. Chen, and L. Feng Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis FASEB J, February 1, 2008; 22(2): 445 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Wunderlich, B. J. Needleman, Z. Chen, J. G. Yu, Y. Wang, I. Grants, D. J. Mikami, W. S. Melvin, H. J. Cooke, and F. L. Christofi Dual purinergic synaptic transmission in the human enteric nervous system Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G554 - G566. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Macedo, G. Pinhal-Enfield, V. Alshits, G. Elson, B. N. Cronstein, and S. J. Leibovich Wound Healing Is Impaired in MyD88-Deficient Mice: A Role for MyD88 in the Regulation of Wound Healing by Adenosine A2A Receptors Am. J. Pathol., December 1, 2007; 171(6): 1774 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gan and A. S. Habib Adenosine as a Non-Opioid Analgesic in the Perioperative Setting Anesth. Analg., August 1, 2007; 105(2): 487 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Raskovalova, A. Lokshin, X. Huang, Y. Su, M. Mandic, H. M. Zarour, E. K. Jackson, and E. Gorelik Inhibition of Cytokine Production and Cytotoxic Activity of Human Antimelanoma Specific CD8+ and CD4+ T Lymphocytes by Adenosine-Protein Kinase A Type I Signaling Cancer Res., June 15, 2007; 67(12): 5949 - 5956. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. D'Alimonte, V. Flati, M. D'Auro, E. Toniato, S. Martinotti, M. P. Rathbone, S. Jiang, P. Ballerini, P. Di Iorio, F. Caciagli, et al. Guanosine Inhibits CD40 Receptor Expression and Function Induced by Cytokines and beta Amyloid in Mouse Microglia Cells J. Immunol., January 15, 2007; 178(2): 720 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Lappas, Y.-J. Day, M. A. Marshall, V. H. Engelhard, and J. Linden Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation J. Exp. Med., November 27, 2006; 203(12): 2639 - 2648. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lukashev, B. Klebanov, H. Kojima, A. Grinberg, A. Ohta, L. Berenfeld, R. H. Wenger, A. Ohta, and M. Sitkovsky Cutting Edge: Hypoxia-Inducible Factor 1{alpha} and Its Activation-Inducible Short Isoform I.1 Negatively Regulate Functions of CD4+ and CD8+ T Lymphocytes J. Immunol., October 15, 2006; 177(8): 4962 - 4965. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hashikawa, M. Takedachi, M. Terakura, S. Yamada, L.F. Thompson, Y. Shimabukuro, and S. Murakami Activation of adenosine receptor on gingival fibroblasts. J. Dent. Res., August 1, 2006; 85(8): 739 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lokshin, T. Raskovalova, X. Huang, L. C. Zacharia, E. K. Jackson, and E. Gorelik Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells. Cancer Res., August 1, 2006; 66(15): 7758 - 7765. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Cavalcante, M. V. Castro, A. R. F. Barreto, G. W. Sullivan, M. Vale, P. R. C. Almeida, J. Linden, J. M. Rieger, F. Q. Cunha, R. L. Guerrant, et al. Effect of Novel A2A Adenosine Receptor Agonist ATL 313 on Clostridium difficile Toxin A-Induced Murine Ileal Enteritis. Infect. Immun., May 1, 2006; 74(5): 2606 - 2612. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Allen-Gipson, J. Wong, J. R. Spurzem, J. H. Sisson, and T. A. Wyatt Adenosine A2A receptors promote adenosine-stimulated wound healing in bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L849 - L855. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. X. Deng, S. Penland, S. Gupta, R. Fiscella, D. P. Edward, H. H. Tessler, and D. A. Goldstein Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1516 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fortin, D. Harbour, M. Fernandes, P. Borgeat, and S. Bourgoin Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide J. Leukoc. Biol., March 1, 2006; 79(3): 574 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Raskovalova, X. Huang, M. Sitkovsky, L. C. Zacharia, E. K. Jackson, and E. Gorelik Gs Protein-Coupled Adenosine Receptor Signaling and Lytic Function of Activated NK Cells J. Immunol., October 1, 2005; 175(7): 4383 - 4391. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ralph, A. N. McEvoy, D. Kane, B. Bresnihan, O. FitzGerald, and E. P. Murphy Modulation of Orphan Nuclear Receptor NURR1 Expression by Methotrexate in Human Inflammatory Joint Disease Involves Adenosine A2A Receptor-Mediated Responses J. Immunol., July 1, 2005; 175(1): 555 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kin, A. J. Zatta, M. T. Lofye, B. S. Amerson, M. E. Halkos, F. Kerendi, Z.-Q. Zhao, R. A. Guyton, J. P. Headrick, and J. Vinten-Johansen Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine Cardiovasc Res, July 1, 2005; 67(1): 124 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ghanem, C. Lovdahl, E. Dare, C. Ledent, B. B. Fredholm, J.-M. Boeynaems, W. Van Driessche, and R. Beauwens Luminal adenosine stimulates chloride secretion through A1 receptor in mouse jejunum Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G972 - G977. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kolachala, V. Asamoah, L. Wang, S. Srinivasan, D. Merlin, and S. V. Sitaraman Interferon-{gamma} Down-regulates Adenosine 2b Receptor-mediated Signaling and Short Circuit Current in the Intestinal Epithelia by Inhibiting the Expression of Adenylate Cyclase J. Biol. Chem., February 11, 2005; 280(6): 4048 - 4057. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sakowicz, A. Szutowicz, and T. Pawelczyk Differential effect of insulin and elevated glucose level on adenosine transport in rat B lymphocytes Int. Immunol., February 1, 2005; 17(2): 145 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Eltzschig, L. F. Thompson, J. Karhausen, R. J. Cotta, J. C. Ibla, S. C. Robson, and S. P. Colgan Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism Blood, December 15, 2004; 104(13): 3986 - 3992. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, D. M. Conrad, J. J. Butler, C. Zhao, J. Blay, and D. W. Hoskin Adenosine Acts through A2 Receptors to Inhibit IL-2-Induced Tyrosine Phosphorylation of STAT5 in T Lymphocytes: Role of Cyclic Adenosine 3',5'-Monophosphate and Phosphatases J. Immunol., July 15, 2004; 173(2): 932 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Perretti and R. J. Flower Annexin 1 and the biology of the neutrophil J. Leukoc. Biol., July 1, 2004; 76(1): 25 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Hammond and R. G. E. Archer Interaction of the Novel Adenosine Uptake Inhibitor 3-[1-(6,7-Diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl]-1,6-dimethyl-2,4(1H,3H)-quinazolinedione Hydrochloride (KF24345) with the es and ei Subtypes of Equilibrative Nucleoside Transporters J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1083 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schnurr, T. Toy, A. Shin, G. Hartmann, S. Rothenfusser, J. Soellner, I. D. Davis, J. Cebon, and E. Maraskovsky Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells Blood, February 15, 2004; 103(4): 1391 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsutsui, J. Schnermann, F. Noorbakhsh, S. Henry, V. W. Yong, B. W. Winston, K. Warren, and C. Power A1 Adenosine Receptor Upregulation and Activation Attenuates Neuroinflammation and Demyelination in a Model of Multiple Sclerosis J. Neurosci., February 11, 2004; 24(6): 1521 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Sullivan, D. D. Lee, W. G. Ross, J. A. DiVietro, C. M. Lappas, M. B. Lawrence, and J. Linden Activation of A2A adenosine receptors inhibits expression of {alpha}4/{beta}1 integrin (very late antigen-4) on stimulated human neutrophils J. Leukoc. Biol., January 1, 2004; 75(1): 127 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Fredholm and P. Svenningsson Adenosine-dopamine interactions: Development of a concept and some comments on therapeutic possibilities Neurology, December 9, 2003; 61(90116): S5 - 9. [Abstract] [Full Text] |
||||
![]() |
T. Hashikawa, M. Takedachi, M. Terakura, T. Saho, S. Yamada, L.F. Thompson, Y. Shimabukuro, and S. Murakami Involvement of CD73 (ecto-5'-nucleotidase) in Adenosine Generation by Human Gingival Fibroblasts J. Dent. Res., November 1, 2003; 82(11): 888 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Headrick, B. Hack, and K. J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
J F Kinsel and M V Sitkovsky Possible targeting of G protein coupled receptors to manipulate inflammation in vivo using synthetic and natural ligands Ann Rheum Dis, November 1, 2003; 62(90002): ii22 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. H. Neemeth, S. J. Leibovich, E. A. Deitch, E. S. Vizi, C. Szabo, and G. Hasko cDNA Microarray Analysis Reveals a Nuclear Factor-{kappa}B-Independent Regulation of Macrophage Function by Adenosine J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1042 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pinhal-Enfield, M. Ramanathan, G. Hasko, S. N. Vogel, A. L. Salzman, G.-J. Boons, and S. J. Leibovich An Angiogenic Switch in Macrophages Involving Synergy between Toll-Like Receptors 2, 4, 7, and 9 and Adenosine A2A Receptors Am. J. Pathol., August 1, 2003; 163(2): 711 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Riksen, G. A. Rongen, H. J. Blom, F. G.M. Russel, G. H.J. Boers, and P. Smits Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia Cardiovasc Res, August 1, 2003; 59(2): 271 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Henttinen, S. Jalkanen, and G. G. Yegutkin Adherent Leukocytes Prevent Adenosine Formation and Impair Endothelial Barrier Function by Ecto-5'-nucleotidase/CD73-dependent Mechanism J. Biol. Chem., June 27, 2003; 278(27): 24888 - 24895. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Platts, J. Linden, and B. R. Duling Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2360 - H2367. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Panther, S. Corinti, M. Idzko, Y. Herouy, M. Napp, A. la Sala, G. Girolomoni, and J. Norgauer Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells Blood, May 15, 2003; 101(10): 3985 - 3990. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Grenier, N. Flamand, J. Pelletier, P. H. Naccache, P. Borgeat, and S. G. Bourgoin Arachidonic acid activates phospholipase D in human neutrophils; essential role of endogenous leukotriene B4 and inhibition by adenosine A2A receptor engagement J. Leukoc. Biol., April 1, 2003; 73(4): 530 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Mabley, P. Pacher, L. Liaudet, F. G. Soriano, G. Hasko, A. Marton, C. Szabo, and A. L. Salzman Inosine reduces inflammation and improves survival in a murine model of colitis Am J Physiol Gastrointest Liver Physiol, January 1, 2003; 284(1): G138 - G144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pouliot, M.-E. Fiset, M. Masse, P. H. Naccache, and P. Borgeat Adenosine Up-Regulates Cyclooxygenase-2 in Human Granulocytes: Impact on the Balance of Eicosanoid Generation J. Immunol., November 1, 2002; 169(9): 5279 - 5286. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Lee and C. W. Emala Preconditioning and Adenosine Protect Human Proximal Tubule Cells in an In Vitro Model of Ischemic Injury J. Am. Soc. Nephrol., November 1, 2002; 13(11): 2753 - 2761. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gounaris Nucleotidase Cascades Are Catalyzed by Secreted Proteins of the Parasitic Nematode Trichinella spiralis Infect. Immun., September 1, 2002; 70(9): 4917 - 4924. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Flamand, M. E. Surette, S. Picard, S. Bourgoin, and P. Borgeat Cyclic AMP-Mediated Inhibition of 5-Lipoxygenase Translocation and Leukotriene Biosynthesis in Human Neutrophils Mol. Pharmacol., August 1, 2002; 62(2): 250 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Leibovich, J.-F. Chen, G. Pinhal-Enfield, P. C. Belem, G. Elson, A. Rosania, M. Ramanathan, C. Montesinos, M. Jacobson, M. A. Schwarzschild, et al. Synergistic Up-Regulation of Vascular Endothelial Growth Factor Expression in Murine Macrophages by Adenosine A2A Receptor Agonists and Endotoxin Am. J. Pathol., June 1, 2002; 160(6): 2231 - 2244. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Thibault, C. Burelout, D. Harbour, P. Borgeat, P. H. Naccache, and S. G. Bourgoin Occupancy of adenosine A2a receptors promotes fMLP-induced cyclic AMP accumulation in human neutrophils: impact on phospholipase D activity and recruitment of small GTPases to membranes J. Leukoc. Biol., February 1, 2002; 71(2): 367 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Okusa A2A adenosine receptor: a novel therapeutic target in renal disease Am J Physiol Renal Physiol, January 1, 2002; 282(1): F10 - F18. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Murakami, T. Hashikawa, T. Saho, M. Takedachi, T. Nozaki, Y. Shimabukuro, and H. Okada Adenosine regulates the IL-1{beta}-induced cellular functions of human gingival fibroblasts Int. Immunol., December 1, 2001; 13(12): 1533 - 1540. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Jackson and R. K. Dubey Role of the extracellular cAMP-adenosine pathway in renal physiology Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. PEDATA, C. CORSI, A. MELANI, F. BORDONI, and S. LATINI Adenosine Extracellular Brain Concentrations and Role of A2A Receptors in Ischemia Ann. N.Y. Acad. Sci., June 1, 2001; 939(1): 74 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. McPherson, K. G. Barringhaus, G. G. Bishop, J. M. Sanders, J. M. Rieger, S. E. Hesselbacher, L. W. Gimple, E. R. Powers, T. Macdonald, G. Sullivan, et al. Adenosine A2A Receptor Stimulation Reduces Inflammation and Neointimal Growth in a Murine Carotid Ligation Model Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 791 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Dubey, Z. Mi, D. G. Gillespie, and E. K. Jackson Dysregulation of Extracellular Adenosine Levels by Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 249 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Oliani, M. J. Paul-Clark, H. C. Christian, R. J. Flower, and M. Perretti Neutrophil Interaction with Inflamed Postcapillary Venule Endothelium Alters Annexin 1 Expression Am. J. Pathol., February 1, 2001; 158(2): 603 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. VIRAG and C. SZABO Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death FASEB J, January 1, 2001; 15(1): 99 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Narravula, P. F. Lennon, B. U. Mueller, and S. P. Colgan Regulation of Endothelial CD73 by Adenosine: Paracrine Pathway for Enhanced Endothelial Barrier Function J. Immunol., November 1, 2000; 165(9): 5262 - 5268. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. HASKÓ, D. G. KUHEL, J.-F. CHEN, M. A. SCHWARZSCHILD, E. A. DEITCH, J. G. MABLEY, A. MARTON, and C. SZABÓ Adenosine inhibits IL-12 and TNF-{alpha} production via adenosine A2a receptor-dependent and independent mechanisms FASEB J, October 1, 2000; 14(13): 2065 - 2074. [Abstract] [Full Text] |
||||
![]() |
K. Yasui, K. Agematsu, K. Shinozaki, S. Hokibara, H. Nagumo, S. Yamada, N. Kobayashi, and A. Komiyama Effects of theophylline on human eosinophil functions: comparative study with neutrophil functions J. Leukoc. Biol., August 1, 2000; 68(2): 194 - 200. [Abstract] [Full Text] |
||||
![]() |
C. P. Barry and S. E. Lind Adenosine-mediated Killing of Cultured Epithelial Cancer Cells Cancer Res., April 1, 2000; 60(7): 1887 - 1894. [Abstract] [Full Text] |
||||
![]() |
N. FLAMAND, S. BOUDREAULT, S. PICARD, M. AUSTIN, M. E. SURETTE, H. PLANTE, E. KRUMP, M.-J. VALLEE, C. GILBERT, P. NACCACHE, et al. Adenosine, a Potent Natural Suppressor of Arachidonic Acid Release and Leukotriene Biosynthesis in Human Neutrophils Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S88 - 94. [Full Text] [PDF] |